A team of researchers has identified the genetic mutation that causes Proteus syndrome, a rare disorder in which tissue and bone grows massively out of proportion. The discovery, which has ...
Corrections & Clarifications: A previous version of this story incorrectly described one of Jerry DeVries' surgeries. Jerry DeVries’ body is constantly changing on him. When he removes a custom molded ...
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL), today announced that the first patient was dosed in the registrational MOSAIC (Miransertib in Overgrowth Syndromes in Adults and ...
A team of researchers has identified the genetic mutation that causes Proteus syndrome, a rare disorder in which tissue and bone grows massively out of proportion. A team of researchers has identified ...
Joseph Merrick had, by all accounts, a short and miserable life in which he was displayed as a carnival attraction called “The Elephant Man.” He was always a subject of medical curiosity, but the ...
ArQule, Inc. ARQL announced that the first patient for the phase I trial on oncology candidate, ARQ 092, for Proteus syndrome has been enrolled. The trial is being conducted by the National Human ...
Proteus syndrome is a rare condition with an incidence of less than one in one million people worldwide. Only a few hundred individuals have been reported in the medical literature. At this time, ...
The National Human Genome Research Institute (NHGRI), a branch of the NIH, has made an agreement with ArQule to support the clinical development of ARQ 092 for the rare disease Proteus syndrome. The ...
A team of researchers has identified the genetic mutation that causes Proteus syndrome, a rare disorder in which tissue and bone grows massively out of proportion. The discovery, which has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results